Genentech agrees trade secret theft settlement with Taiwan’s JHL

trastuzumab) and Avastin (bevacizumab) – Roche’s ‘big three’ antibody products. ... JHL has been developing biosimilars of Rituxan, Herceptin and Avastin, which have all lost patent protection, and has a  partnership with Sanofi for the Rituxan

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO

its ‘big three’ antibiotic products – Rituxan, Herceptin and Avastin – which accounted for more than a third of sales last year.

AZ, Merck’s Lynparza scores market-expanding clinical success

trial. Thephase 3Paola-1trial randomised women to receive Avastin with or without PARP inhibitor Lynparza in a first-line maintenance setting. ... Around 15% of ovarian cancer patients have germline BRCA mutations. Many of the remaining 85% of patients

Mistrust of pharma still blocking NHS collaborations

There are of course plenty of examples where pharma and the NHS have clashed over costs – perhaps most notably the legal battle over Avastin being used in place of licensed blindness

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]